Monday - January 12, 2026

Category Archives: Pharmaceuticals & Biotech

Ibogaine by David Dardashti Announces Breakthrough Treatment Protocol Targeting Archetypal Duality in Veteran Trauma

MIAMI, FL – Ibogaine by David Dardashti, a leading research and treatment center specializing in sub-perceptual and high-dose ibogaine protocols, has announced an expansive new treatment framework designed specifically for military veterans. The protocol addresses a critical psychological phenomenon: the collapse … Continue reading →

Fabry Disease Market Positioned for Accelerated Development Through 2034, DelveInsight Finds | Sanofi Genzyme, Sangamo Therapeutics, Freeline Therapeutics, AVROBIO, 4D Molecular Therapeutics

The Key Fabry Disease Companies in the market include – Chiesi and Protalix Biotherapeutics, Sanofi Genzyme, Sangamo Therapeutics, Protalix Biotherapeutics, AVROBIO, Sanofi Genzyme, Sangamo Therapeutics, Freeline Therapeutics, 4D Molecular Therapeutics, Idorsia Pharmaceuticals, Greenovation Biotech GMBH, ICON plc, Chiesi Farmaceutici S.p.A., … Continue reading →

Allergic Rhinitis Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Inmunotek, Iltoo Pharma, Advagene Biopharma Co. Ltd., AOBiome LLC, Emergo Therapeutics

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Allergic Rhinitis pipeline constitutes 35+ key companies continuously working towards developing 35+ Allergic Rhinitis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes … Continue reading →

Amyotrophic Lateral Sclerosis Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes | Helixmith, Sanofi, Denali Therapeutics, Transposon Therapeutics, GSK, Biogen, Ionis Pharma

The Key Amyotrophic Lateral Sclerosis Companies in the market include – Helixmith, Sanofi, Denali Therapeutics, Transposon Therapeutics, Alector, GSK, NeuroSense Therapeutics, Biogen, Ionis Pharmaceuticals, Brainstorm Cell Therapeutics, Cytokinetics, Astellas Pharma, Apellis Pharmaceuticals, Clene Nanomedicine Biosciences, AL-S Pharma, MediciNova, and others. … Continue reading →

Acute Kidney Injury Market Insights Highlight Expanding Outlook Till 2034, DelveInsight Evaluates | Ocelot Bio, Angion Biomedica, Alloksys, Guard Therapeutics, Vifor Pharma, AM Pharma, Astellas Pharma

The Key Acute Kidney Injury Companies in the market include – Alloksys, Guard Therapeutics, Ocelot Bio, Angion Biomedica/Vifor Pharma AM Pharma, Astellas Pharma, Sentien Biotechnologies, RegeneRx Biopharmaceuticals, and others.   DelveInsight’s “Acute Kidney Injury Market Insights, Epidemiology, and Market Forecast-2034″ … Continue reading →

Sjogren’s Syndrome Market to Experience Notable Growth in Forecast Span by 2034, DelveInsight Predicts | Astellas Pharma, Immunovant Sciences, NK Cells Artiva Biotherapeutics, Rise Therapeutics

The Key Sjogren’s syndrome Companies in the market include – Astellas Pharma, Immunovant Sciences, NK Cells Artiva Biotherapeutics, Rise Therapeutics, Bristol-Myers Squibb, Resolve Therapeutics, Novartis, Horizon Therapeutics, Dompe Farmaceutici, Horizon Therapeutics (Amgen), Sylentis, OSE Immunotherapeutics, Servier, Johnson & Johnson, and … Continue reading →

BIIC-Tech Huazhi’s Domestically Developed Mass Spectrometer Wins Peking University Procurement Bid with High Scores: BIIC-Tech’s Long-Term Investment Forges Core Strength

Recently, the bid-winning result for the Procurement Project of Liquid Chromatography-Ion Chromatography Triple Quadrupole Mass Spectrometer of the College of Chemistry and Molecular Engineering, Peking University was officially announced. Beijing BIIC-Tech Huazhi Scientific Instruments Co., Ltd. (hereinafter referred to as … Continue reading →